Literature DB >> 22080707

Utility of a point-of-care device in recruiting ethnic minorities for diabetes research with community partners.

Soohyun Nam1, Hae-Ra Han, Hee-Jung Song, Yongshin Song, Kim B Kim, Miyong T Kim.   

Abstract

BACKGROUND: Recruitment of hard-to-reach ethnic minorities such as Korean Americans (KAs) requires substantial time, cost, and strategic effort. A point-of-care (POC) A1c test could facilitate the recruitment of such populations for diabetes research in community settings.
METHODS: A two-step approach for participant screening was employed: Potential participants were first screened using the POC A1c test at a community location. Only those with POC A1c levels ≥7.5% were referred for a confirmatory lab test within two weeks.
RESULTS: In total, 237 KAs were screened using the POC A1c test; 92 were referred for confirmatory testing and 83 who got the laboratory A1c measurement were confirmed eligible (A1c ≥7.5%). There was a strong positive correlation between the POC and reference laboratory measurements (ρ=0.83, p≤.001).
CONCLUSION: Using a POC A1c method as a front-line screening test can facilitate the recruitment of KAs with type 2 diabetes, while saving cost, time, and effort.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080707      PMCID: PMC3649516          DOI: 10.1353/hpu.2011.0117

Source DB:  PubMed          Journal:  J Health Care Poor Underserved        ISSN: 1049-2089


  23 in total

1.  Acculturation and health in Korean Americans.

Authors:  S K Lee; J Sobal; E A Frongillo
Journal:  Soc Sci Med       Date:  2000-07       Impact factor: 4.634

2.  Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).

Authors:  Laurence Kennedy; William H Herman
Journal:  Diabetes Technol Ther       Date:  2005-12       Impact factor: 6.118

3.  Barriers to and strategies for recruiting Korean Americans for community-partnered health promotion research.

Authors:  Hae-Ra Han; Jeonghee Kang; Kim B Kim; Jai P Ryu; Miyong T Kim
Journal:  J Immigr Minor Health       Date:  2007-04

Review 4.  Review of community-based research: assessing partnership approaches to improve public health.

Authors:  B A Israel; A J Schulz; E A Parker; A B Becker
Journal:  Annu Rev Public Health       Date:  1998       Impact factor: 21.981

5.  Usefulness of point-of-care testing in the treatment of diabetes in an underserved population.

Authors:  Sandra Leal; Marisa Soto-Rowen
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

6.  Cultural barriers between obstetrician-gynecologists and Vietnamese/Chinese immigrant women.

Authors:  H H Vu
Journal:  Tex Med       Date:  1996-10

7.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.

Authors:  E Cagliero; E V Levina; D M Nathan
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

8.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

9.  Rapid A1c availability improves clinical decision-making in an urban primary care clinic.

Authors:  Christopher D Miller; Catherine S Barnes; Lawrence S Phillips; David C Ziemer; Daniel L Gallina; Curtiss B Cook; Sandra D Maryman; Imad M El-Kebbi
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

10.  Assessment of glycated hemoglobin using A1CNow+ point-of-care device as compared to central laboratory testing.

Authors:  Justin R Arrendale; Sonia E Cherian; Issam Zineh; Mark J Chirico; James R Taylor
Journal:  J Diabetes Sci Technol       Date:  2008-09
View more
  1 in total

Review 1.  Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.

Authors:  Deborah Taira Juarez; Kendra M Demaris; Roy Goo; Christina Louise Mnatzaganian; Helen Wong Smith
Journal:  Diabetes Metab Syndr Obes       Date:  2014-10-20       Impact factor: 3.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.